Cencoravs.CVS Health
COR vs CVS · both in Distribution & pharmacy infrastructure, part of the Medicine, pharma & life science value chain: Wholesalers, distribution and pharmacy chains that get medicines to patients.
CVS Health is about 2.2× larger than Cencora by market cap; Cencora trades at the lower P/E (23.2 vs 45.3); year to date, CVS Health leads (+31.2% vs −10.2%).
Side by side
| COR | CVS | |
|---|---|---|
| Market cap | $59.2B | $133B |
| Price | $303.44 | $104.15 |
| Today | +0.3% | +1.3% |
| Return YTD | −10.2% | +31.2% |
| Return 1Y | +2.1% | +58.7% |
| P/E | 23.2 | 45.3 |
| P/S | 0.2 | 0.3 |
| P/B | 17.4 | 1.7 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
CencoraCOR
American pharmaceutical wholesaler (formerly AmerisourceBergen) — distributes medicines and specialty drugs to the healthcare sector.
Full COR profile →CVS HealthCVS
American healthcare group with a pharmacy chain, health insurance (Aetna) and a pharmacy benefit manager (Caremark).
Full CVS profile →More comparisons in Distribution & pharmacy infrastructure
See where COR and CVS sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →